Literature DB >> 11477402

Toll-like receptors: critical proteins linking innate and acquired immunity.

S Akira1, K Takeda, T Kaisho.   

Abstract

Recognition of pathogens is mediated by a set of germline-encoded receptors that are referred to as pattern-recognition receptors (PRRs). These receptors recognize conserved molecular patterns (pathogen-associated molecular patterns), which are shared by large groups of microorganisms. Toll-like receptors (TLRs) function as the PRRs in mammals and play an essential role in the recognition of microbial components. The TLRs may also recognize endogenous ligands induced during the inflammatory response. Similar cytoplasmic domains allow TLRs to use the same signaling molecules used by the interleukin 1 receptors (IL-1Rs): these include MyD88, IL-1R--associated protein kinase and tumor necrosis factor receptor--activated factor 6. However, evidence is accumulating that the signaling pathways associated with each TLR are not identical and may, therefore, result in different biological responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477402     DOI: 10.1038/90609

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  1321 in total

Review 1.  Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.

Authors:  Ralph Marvin Steinman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

Review 2.  Toll receptors: a central element in innate immune responses.

Authors:  Thierry Vasselon; Patricia A Detmers
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

3.  Pellino 2 is critical for Toll-like receptor/interleukin-1 receptor (TLR/IL-1R)-mediated post-transcriptional control.

Authors:  Tae Whan Kim; Minjia Yu; Hao Zhou; Wei Cui; Jianan Wang; Paul DiCorleto; Paul Fox; Hui Xiao; Xiaoxia Li
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

4.  Vitamin D attenuates HMGB1-mediated neointimal hyperplasia after percutaneous coronary intervention in swine.

Authors:  Mohan Satish; Palanikumar Gunasekar; Juan A Asensio; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2020-08-01       Impact factor: 3.396

5.  An immune-stimulating proteoglycan from the medicinal mushroom Huaier up-regulates NF-κB and MAPK signaling via Toll-like receptor 4.

Authors:  Ailin Yang; Haitao Fan; Yanan Zhao; Xiaonan Chen; Zhixiang Zhu; Xiaojun Zha; Yunfang Zhao; Xingyun Chai; Jun Li; Pengfei Tu; Zhongdong Hu
Journal:  J Biol Chem       Date:  2019-01-02       Impact factor: 5.157

6.  Toll-like receptor 2 deficiency is associated with enhanced severity of group B streptococcal disease.

Authors:  Manuela Puliti; Satoshi Uematsu; Shizuo Akira; Francesco Bistoni; Luciana Tissi
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

7.  Efficacy of colistin-impregnated beads to prevent multidrug-resistant A. baumannii implant-associated osteomyelitis.

Authors:  Daniel P Crane; Kirill Gromov; Dan Li; Kjeld Søballe; Christian Wahnes; Hubert Büchner; Matthew J Hilton; Regis J O'Keefe; Clinton K Murray; Edward M Schwarz
Journal:  J Orthop Res       Date:  2009-08       Impact factor: 3.494

8.  Gene expression based evidence of innate immune response activation in the epithelium with oral lichen planus.

Authors:  Guy R Adami; Alexander C F Yeung; Grant Stucki; Antonia Kolokythas; Herve Y Sroussi; Robert J Cabay; Igor Kuzin; Joel L Schwartz
Journal:  Arch Oral Biol       Date:  2014-01-04       Impact factor: 2.633

9.  Marek's disease virus may interfere with T cell immunity by TLR3 signals.

Authors:  Xuming Hu; Wencai Xu; Aijian Qin; Genghua Wu; Kun Qian; Hongxia Shao; Jianqiang Ye
Journal:  Vet Res Commun       Date:  2014-03-02       Impact factor: 2.459

10.  Localization of type I interferon receptor limits interferon-induced TLR3 in epithelial cells.

Authors:  Jonathan M Ciencewicki; Luisa E Brighton; Ilona Jaspers
Journal:  J Interferon Cytokine Res       Date:  2009-05       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.